Measurement of ribavirin and evaluation of its stability in human plasma by high-performance liquid chromatography with UV detection

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 856, Issue 1-2, 2007, Pages 358-364

  Loregian, Arianna ^a,b   Scarpa, Maria Cristina ^a   Pagni, Silvana ^a,b   Parisi, Saverio Giuseppe ^b   Palù, Giorgio ^a,b  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

High performance liquid chromatography; Human plasma; Ribavirin; Ribavirin stability; Solid phase extraction; Therapeutic drug monitoring; UV method

Indexed keywords

HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PHASE SEPARATION; PLASMA (HUMAN); ULTRAVIOLET DETECTORS;

RIBAVIRIN STABILITY; SOLID-PHASE EXTRACTION; THERAPEUTIC DRUG MONITORING; UV METHODS;

DRUG PRODUCTS;

BORONIC ACID DERIVATIVE; POTASSIUM DIHYDROGEN PHOSPHATE; RIBAVIRIN;

ACCURACY; ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DRUG BLOOD LEVEL; DRUG STABILITY; FREEZE THAWING; HEPATITIS C; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LABORATORY; PATIENT MONITORING; PH MEASUREMENT; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ROOM TEMPERATURE; SENSITIVITY ANALYSIS; SOLID PHASE EXTRACTION; THERMOSTABILITY; ULTRAVIOLET RADIATION; VALIDATION PROCESS;

ANTIVIRAL AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; REPRODUCIBILITY OF RESULTS; RIBAVIRIN; SENSITIVITY AND SPECIFICITY; SPECTROPHOTOMETRY, ULTRAVIOLET;

HEPATITIS C VIRUS;

EID: 34548119822     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2007.05.039     Document Type: Article

References (29)

1. Sidwell R.W., Huffman J.H., Khare G.P., Allen L.B., Witkowski J.T., and Robins R.K. Science 177 (1972) 705
2. Witkowski J.T., Robins R.K., Sidwell R.W., and Simon L.N. J. Med. Chem. 15 (1972) 1150
3. Gilbert B.E., and Knight V. Antimicrob. Agents Chemother. 30 (1986) 201
4. Fried M.W., Shiffman M.L., Reddy K.R., Smith C., Marinos G., Goncales Jr. F.L., Haussinger D., Diago M., Carosi G., Dhumeaux D., Craxi A., Lin A., Hoffman J., and Yu J. N. Engl. J. Med. 347 (2002) 975
5. Manns M.P., McHutchison J.G., Gordon S.C., Rustgi V.K., Shiffman M., Reindollar R., Goodman Z.D., Koury K., Ling M., and Albrecht J.K. Lancet 358 (2001) 958
6. Rockstroh J.K., and Spengler U. Lancet Infect. Dis. 4 (2004) 437
7. Rockstroh J.K., and Vogel M. Eur. J. Med. Res. 9 (2004) 304
8. Larrat S., Stanke-Labesque F., Plages A., Zarski J.P., Bessard G., and Souvignet C. Antimicrob. Agents Chemother. 47 (2003) 124
9. Glue P. Semin. Liver Dis. 19 Suppl. 1 (1999) 17
10. Scott L.J., and Perry C.M. Drugs 62 (2002) 507
11. Kowdley K.V. J. Clin. Gastroenterol. 39 (2005) S3
12. Rendon A.L., Nunez M., Romero M., Barreiro P., Martin-Carbonero L., Garcia-Samaniego J., Jimenez-Nacher I., Gonzalez-Lahoz J., and Soriano V. J. Acquir. Immune Defic. Syndr. 39 (2005) 401
13. Smee D.F., Sidwell R.W., Barnett B.B., and Spendlove R.S. Chemotherapy 27 (1981) 1
14. Austin R.K., Trefts P.E., Hintz M., Connor J.D., and Kagnoff M.F. Antimicrob. Agents Chemother. 24 (1983) 696
15. Roboz J., and Suzuki R. J. Chromatogr. 160 (1978) 169
16. Breadmore M.C., Theurillat R., and Thormann W. Electrophoresis 25 (2004) 1615
17. Granich G.G., Krogstad D.J., Connor J.D., Desrochers K.L., and Sherwood C. Antimicrob. Agents Chemother. 33 (1989) 311
18. Svensson J.O., Bruchfeld A., Schvarcz R., and Stahle L. Ther. Drug Monit. 22 (2000) 215
19. Inoue Y., Homma M., Matsuzaki Y., Shibata M., Matsumura T., Ito T., Mitamura K., Tanaka N., and Kohda Y. Antimicrob. Agents Chemother. 48 (2004) 3813
20. D'Avolio A., Ibanez A., Sciandra M., Siccardi M., de Requena D.G., Bonora S., and Di Perri G. J. Chromatogr. B 835 (2006) 127
21. Shou W.Z., Bu H.Z., Addison T., Jiang X., and Naidong W. J. Pharm. Biomed. Anal. 29 (2002) 83
22. Lin C.C., Yeh L.T., and Lau J.Y. J. Chromatogr. B 779 (2002) 241
23. Liu Y., Xu C., Yan R., Lim C., Yeh L.T., and Lin C.C. J. Chromatogr. B 832 (2006) 17
24. Li W., Luo S., Li S., Athill L., Wu A., Ray T., Zhou W., Ke J., Smith H.T., and Tse F.L. J. Chromatogr. B 846 (2007) 57
25. Spire B., Dormont D., Barre-Sinoussi F., Montagnier L., and Chermann J.C. Lancet 1 (1985) 188
26. B.D. Lindenbach, C.M. Rice, in H.P.M. D.M. Knipe, D.E. Griffin, R.A. Lamb, M.A. Martin, B. Roizman, S.E. Straus (Eds.), Fields Virology, Lippincott, Williams, Wilkins, Philadelphia, PA, 2001, p. 1675.
27. US Food and Drug Administration: Center for Drug Evaluation and Research. Guidance for Industry: Bioanalytical Method Validation, http://www.fda.gov/cder/guidance/4252fnl.htm, May 2001.
28. Khakoo S., Glue P., Grellier L., Wells B., Bell A., Dash C., Murray-Lyon I., Lypnyj D., Flannery B., Walters K., and Dusheiko G.M. Br. J. Clin. Pharmacol. 46 (1998) 563
29. Jen J.F., Glue P., Gupta S., Zambas D., and Hajian G. Ther. Drug Monit. 22 (2000) 555